News & Articles

The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19

Discover the latest research applications using multiplex technology to maximize sample use, while saving time and money

The serology test promises 100% sensitivity and can help assess patients' immune response to the virus

The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment

Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.

Collaboration will enable global development, manufacturing and distribution of the vaccine

These models aim to accelerate treatment development prior to clinical trials

The test will be available for qualified laboratories across the European Union by the end of May

The MicronJet microneedle device to enable the development of a safe, effective and affordable vaccine

Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19

Comprehensive turnkey system based on LabVantage LIMS platform allows laboratories to implement COVID-19 Biobanking, testing and research

Learn how one immunology lab upgraded its cell counter to discriminate cells in a mixed population and streamline viability counts

Join this expert webinar to find out about applications for cell-based therapies and biologics using advanced high-throughput flow cytometry

Join this webinar to discover how cytometry can be used to monitor immune responses to new therapeutics and how the Maxpar Direct Immune Profiling System can help meet the demands of your COVID-19 research

The company is offering technical and scientific support along with supply chain continuity and instrument contributions

Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April

Pioneering new class of diagnostic product will transform fight against pandemic

UCL academics are working with Causaly to help accelerate research into the COVID-19 pandemic, including the identification of biomarkers and potential therapeutic agents